drugset / Trial / NCT00317135
Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.
RandomizedParallel-groupPrevention
Summary
The purpose of this study is to compare the reactogenicity \& safety of Tritanrix™-HepB/Hib-MenAC vaccine to the international standard of care, Tritanrix™-HepB/Hiberix™.
Timeline
- Start
- 2003-12-11
- Primary completion
- 2004-10-23
- Completion
- 2004-10-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN | Vaccine | — | Intramuscular |
| Subject | Meningitec | Vaccine | — | Intramuscular |
| Comparator | Tritanrix-HepB | Vaccine | — | Intramuscular |